Precision Biologics highlights tumor-specific monoclonal antibodies at Festival of Biologics USA. Discover how neoepitope targeting could reshape cancer therapy.
TAG1 and Dana-Farber partner to expand Lead-212 access for targeted alpha therapies. Discover what this means for radiopharmaceutical oncology innovation.
Senhwa Biosciences and CellType partner to advance silmitasertib with AI. Discover how the collaboration could reshape immunotherapy research.
Hua Medicine’s dorzagliatin wins Hong Kong approval for Type 2 diabetes. Discover what this glucokinase activator milestone means for global diabetes treatment.
Peli BioThermal and Polar Group expand pharmaceutical cold chain solutions in Brazil. Discover what the partnership reveals about biologics logistics.
China approves CEVIRA, the first non-invasive therapy for CIN2 cervical precancer. Discover what this means for treatment pathways and global adoption.
Matricelf plans a subsidiary to commercialize its Parkinson’s therapy platform. Discover what this move signals for regenerative medicine and neurology innovation.
Pierre Fabre Pharmaceuticals seeks an FDA path forward for tabelecleucel in EBV-positive PTLD after a Complete Response Letter. Discover what regulators may scrutinize next.
DarioHealth targets oral GLP-1 therapy support with behavioral digital tools. Discover how digital health platforms could reshape obesity and diabetes treatment.
FDA grants rare hearing to review Vanda Pharmaceuticals’ HETLIOZ jet lag application. Discover what this regulatory fight could mean for circadian medicine.